COMP <GO>
NAKA vs LFMD // PIOTROSKI F-SCORE QUALITY
Nakamoto Inc. (NASDAQ) VS. LifeMD Inc. (NASDAQ) • 15-METRIC TALLY: NAKA 1
— LFMD 8
▲ PIOTROSKI F-SCORE QUALITY LEADER: LFMD
LAST: $6.88 (-3.51%) • MKT CAP: $126.2M
piotroski-score
2/9
LAST: $2.32 (+4.04%) • MKT CAP: $111.8M
piotroski-score
6/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NAKA VS. LFMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NAKA | LFMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 85.70% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -31.60% | -26.20% | -5.40 | LFMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -18.63% | 5.73% | -24.36 | LFMD | /fcf-yield <GO> |
| Operating Margin | -60.00% | -4.00% | -56.00 | LFMD | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -5.80% | -54.20 | LFMD | /net-margins <GO> |
| Revenue Growth (YoY) | -33.00% | 25.30% | -58.30 | LFMD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.78% | -2.78 | LFMD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 0.20 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 2/9 | 6/9 | -4.00 | LFMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 33.9 | 38.8 | -4.88 | LFMD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $126.2M | $111.8M | $14.4M | NAKA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NAKA REV | LFMD REV | NAKA GROSS % | LFMD GROSS % | NAKA FCF | LFMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.8M | $194.1M | — | 85.7% | -$23.5M | $6.4M |
| FY 2024 | $2.7M | $154.8M | — | 86.2% | -$3.1M | $16.0M |
| FY 2023 | $3.8M | $152.5M | — | — | -$449.5K | $8.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NAKA // BETA —
LFMD // BETA —